HD
The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the monoclonal antibody treatment for COVID-19 developed by Regeneron Pharmaceuticals and F. Hoffmann-La Roche AG.
The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the monoclonal antibody treatment for COVID-19 developed by Regeneron Pharmaceuticals and F. Hoffmann-La Roche AG.
Contact your sales representative for commercial and promotional uses.